Le cannabis produit de nombreux effets psychologiques et physiologiques sur le corps humain. Les molécules contenues dans cette plante, désignées comme « phytocannabinoïdes », activent un système endogène qu’on appelle le système endocannabinoïde (eCB). Les effets de la consommation de cannabis sur la vision ont déjà été décrits sans cependant de formulation sur les mécanismes sous-jacents. Ces résultats comportementaux suggèrent, malgré tout, la présence de ce système eCB dans le système visuel, et particulièrement dans la rétine. Cette thèse vise donc à caractériser l’expression, la localisation et le rôle du système eCB dans la rétine du singe vervet, une espèce animale ayant un système visuel semblable à celui de l’humain. Nous avons mis au point un protocole expérimental d’immunohistochimie décrit dans l’article apparaissant dans l’Annexe I que nous avons utilisé pour répondre à notre objectif principal. Dans une première série de quatre articles, nous avons ainsi caractérisé l’expression et la localisation de deux récepteurs eCBs reconnus, les récepteurs cannabinoïdes de type 1 (CB1R) et de type 2 (CB2R), et d’un 3e présumé récepteur aux cannabinoïdes, le récepteur GPR55. Dans l’article 1, nous avons démontré que CB1R et une enzyme clé de ce système, la fatty acid amide hydrolase (FAAH), sont exprimés dans les parties centrale et périphérique de la rétine, et abondamment présents dans la fovéa, une région où l’acuité visuelle est maximale. Dans l’article 2, nous avons localisé le CB2R dans des cellules gliales de la rétine : les cellules de Müller et nous avons proposé un modèle sur l’action de cette protéine dans la fonction rétinienne faisant appel à une cascade chimique impliquant les canaux potassiques. Dans l’article 3, nous avons observé le GPR55 exclusivement dans les bâtonnets qui sont responsables de la vision scotopique et nous avons soumis un deuxième modèle de fonctionnement de ce récepteur par le biais d'une modulation des canaux calciques et sodiques des bâtonnets. Vu que ces 3 récepteurs se retrouvent dans des cellules distinctes, nous avons suggéré leur rôle primordial dans l’analyse de l’information visuelle au niveau rétinien. Dans l’article 4, nous avons effectué une analyse comparative de l’expression du système eCB dans la rétine de souris, de toupayes (petits mammifères insectivores qui sont sont considérés comme l’étape intermédiaire entre les rongeurs et les primates) et de deux espèces de singe (le vervet et le rhésus). Ces résultats nous ont menés à présenter une hypothèse évolutionniste quant à l’apparition et à la fonction précise de ces récepteurs. Dans les articles subséquents, nous avons confirmé notre hypothèse sur le rôle spécifique de ces trois récepteurs par l’utilisation de l’électrorétinographie (ERG) après injection intravitréenne d’agonistes et d’antagonistes de ces récepteurs. Nous avons conclu sur leur influence indéniable dans le processus visuel rétinien chez le primate. Dans l’article 5, nous avons établi le protocole d’enregistrement ERG normalisé sur le singe vervet, et nous avons produit un atlas d’ondes ERG spécifique à cette espèce, selon les règles de l’International Society for Clinical Electrophysiology of Vision (ISCEV). Les patrons électrorétinographiques se sont avérés semblables à ceux de l’humain et ont confirmé la similarité entre ces deux espèces. Dans l’article 6, nous avons démontré que le blocage de CB1R ou CB2R entraine une modification de l’électrorétinogramme, tant au niveau photopique que scotopique, ce qui supporte l’implication de ces récepteurs dans la modulation des ondes de l’ERG. Finalement, dans l’article 7, nous avons confirmé le modèle neurochimique proposé dans l’article 3 pour expliquer le rôle fonctionnel de GPR55, en montrant que l’activation ou le blocage de ce récepteur, respectivement par un agoniste (lysophosphatidylglucoside, LPG) ou un antagoniste (CID16020046), entraine soit une augmentation ou une baisse significative de l’ERG scotopique seulement. Ces données, prises ensemble, démontrent que les récepteurs CB1R, CB2R et GPR55 sont exprimés dans des types cellulaires bien distincts de la rétine du singe et ont chacun un rôle spécifique. L’importance de notre travail se manifeste aussi par des applications cliniques en permettant le développement de cibles pharmacologiques potentielles dans le traitement des maladies de la rétine. / Cannabis produces a range of psychological and physiological effects on the human body. Cannabinoids are the chemical compounds found in cannabis that activate an endogenous system, termed the endocannabinoid (eCB) system. Reports made in the 1970s have noted that cannabis consumption affects vision. It is therefore suggested that the eCB system is present in the visual system, particularly in the retina. This thesis aims at characterizing the expression, localization, and role of the eCB system in the vervet monkey retina. This animal model has a similar visual system as humans. Using immunohistochemistry methods presented in the article of Annexe I, we have established an experimental protocol to answer our goal. In the first series of four articles, we have characterized the expression and localization of the cannabinoid receptor 1 (CB1R), cannabinoid receptor 2 (CB2R), and the putative cannabinoid receptor GPR55. In Article 1, we have demonstrated that CB1R and a key enzyme of this system, FAAH (fatty acid amide hydrolase), are expressed in the central and peripheral retina, but heavily present in the fovea, the retinal region responsible for high acuity vision. In Article 2, we have localized CB2R in the glial Müller cells and hypothesized a possible mechanism of action of CB2R involving potassium buffering. In Article 3, we found that GPR55 is exclusively expressed in rods and have proposed its role through the modulation of calcium and sodium channels in rods. Given that these three receptors are segregated in the vervet monkey retina, we suggested that they might have distinct roles in retinal physiology. In Article 4, we reported a comparative analysis of the expression of the eCB system components in the retina of rodents, tree shrews (small mammals considered as early primates), and monkeys. This paper provides evidence that the eCB system is differently expressed in the retina of these mammals and suggests a distinctive role of eCBs in visual processing. In the subsequent series of three articles, we confirmed their suggested roles in the retina by using electroretinography (ERG) and intravitreal injections of agonist and antagonist of these receptors. We concluded that they indeed play important roles in the retina. In Article 5, we developed a standard protocol for ERG testing in our animal model and have published an ERG atlas with normalized amplitudes and latency values similar to that of humans, following the guidelines of the International Society for Clinical Electrophysiology of Vision. In Article 6, we showed that blockade of CB1R or CB2R with specific antagonists modifies the ERG, both in photopic and scotopic conditions, which confirms the implication of these receptors in normal retinal function. Finally, in Article 7 (expression of GPR55 in rods only), we confirmed the suggest role of GPR55 in rods by showing that activation or blockade of GPR55 with a specific agonist (lysophosphatidylglucoside) or antagonist (CID16020046) increases or decreases the amplitude of the scotopic ERG waveforms. Taken together, these articles demonstrate that CB1R, CB2R, and GPR55 are differentially expressed in the vervet monkey retina and have distinct roles. This work has also clinical relevance in the way that we have discovered new pharmacological targets that can be used for treatment of many retinal diseases.

O sistema canabinóide parece participar de vários processos neurobiológicos, incluindo neuroproteção e plasticidade. Os objetivos deste estudo foram avaliar os efeitos de ablações retinianas sobre a expressão do receptor canabinóide CB1 e de proteínas estruturais no tecto óptico de pintos pelos métodos de imuno-histoquímica, immunoblotting e PCR em tempo real. Além disso, avaliamos os efeitos do tratamento com agonistas e antagonistas canabinóides em culturas de células do tecto óptico expostas ao NMDA por citometria de fluxo e quanto à morfologia. A ablação retiniana parece gerar um aumento da expressão da proteína CB1 no tecto óptico desaferentado, mas não dos níveis de RNAm. O tratamento das culturas com o agonista canabinóide diminuiu o número de células inviáveis e de DNA fragmentado gerados pelo NMDA. O aumento da expressão de CB1 após a ablação indica uma localização pós-sináptica desses receptores e sugere um papel do sistema canabinóide em processos de plasticidade. Os resultados da cultura de células sugerem um papel neuroprotetor do sistema canabinóide. / The cannabinoid system (CS) seems to have a role in several neurobiological processes, including neuroprotection and neuronal plasticity. The aims of this study were to verify the effects of unilateral retinal ablation on the expression of cannabinoid receptor CB1 and other structural proteins in the optic tectum of chick brain by immunohistochemistry, immunoblotting and real time PCR. Moreover, we evaluated the effects of cannabinoids agonists and antagonists treatment in optic tectum cell cultures exposed to the NMDA by flow cytometry and in the morphology. The retinal ablation seems to generate an increase in the expression of protein CB1 in the deafferented optic tectum, but not in the levels of mRNA. The treatment of the cultures with the cannabinoid agonist decreased the number of unviable cells and fragmented DNAs generated by NMDA. This increase of CB1 expression indicates a post-synaptic localization of these receptors and suggests a role of the CS in plasticity processes. The results of cell culture suggest neuroprotector role of the CS.

Classically, endogenous fatty acid ethanolamides and their derivatives that bind to the cannabinoid receptors and trigger a signalling pathway are referred to as endocannabinoids. Although derivatives of arachidonic acid, including arachidonylethanolamine or anandamide, are the known endogenous ligands for cannabinoid receptors, other fatty acid ethanolamides or N-acylethanolamines (NAE) that vary in carbon chain length and saturation occur ubiquitously in eukaryotic organisms and play an important role in their physiology and development. The metabolic pathway for NAEs is highly conserved among eukaryotes and well characterised in mammalian systems. Although NAE pathway is only partly elucidated in plants, significant progress has been made in the past 20 years in understanding the implications of the metabolism of saturated and unsaturated endocannabinoid-like molecules in plant development and growth. The latest advancements in the field of plant endocannabinoid research are reviewed. Key Concepts Endocannabinoids are endogenous ligands of cannabinoid receptors in mammalian systems. Endocannabinoids belong to a class of small bioactive lipid molecules that are derivatives of fatty acids including their ethanolamides, referred to as N-acylethanolamines. N-Acylethanolamines are ubiquitous and their metabolic pathway is highly conserved among eukaryotes. In higher plants, only 12–18C N-acylethanolamines have been identified and their metabolic pathway is partly elucidated. The endocannabinoid-like lipids play an important role in seed germination, seedling development, flowering and cellular organisation. In plants, N-acylethanolamines also participate in mediating responses to biotic and abiotic stress.

Cannabinoids have been shown to alter synaptic plasticity but the mechanism by which this occurs at hippocampal CA3-CA1 synapses in vivo is not yet known. Utilizing in vivo electrophysiological recordings of field excitatory postsynaptic potentials (fEPSP) on anesthetized rats and mice as well as three lines of conditional knockout mouse models, the objective was to show a two-part mechanistic breakdown of cannabinoid-evoked CA3-CA1 long-term depression (LTD) in its induction as well as early and later-phase expression stages. It was determined that this cannabinoid-induced in vivo LTD requires cannabinoid type-1 receptors (CB1Rs) on astrocytes, but not CB1Rs on glutamatergic or GABAergic neuronal axons/terminals. Pharmacological testing determined that cannabinoid-induced in vivo LTD also requires activation of NMDA receptors (NMDAR) and subsequent postsynaptic endocytosis of AMPA receptors (AMPAR). There exists a clear role for NR2B-containing NMDARs in a persistent, transitory form, potentially related to prolonged or delayed glutamate release (possibly as a result of the astrocytic network). A key determination of the expression phase is the involvement of new protein synthesis (using translation and transcription inhibitors) – further evidence of the long-term action of the synaptic plasticity from a single cannabinoid dose.

Dissertation (Ph.D.)--University of South Florida, 2009. / Title from PDF of title page. Document formatted into pages; contains 92 pages. Includes vita. Includes bibliographical references.

La schizophrénie est une maladie complexe et a une prévalence approximative de 1% dans la population générale. Au sein des paradigmes neurochimiques, la théorie étiologique de la dopamine est celle qui prévaut alors que sont de plus en plus impliqués d’autres circuits de neurotransmission comme celui du glutamate. En clinique, les patients atteints de schizophrénie ont une grande propension à consommer des substances, particulièrement du cannabis. Nous avons cherché à étayer l’hypothèse d’un désordre du système cannabinoïde endogène, un important neuromodulateur. Ce mémoire propose d’abord dans un premier article une revue exhaustive de la littérature explorant le système endocannabinoïde et ses implications dans la schizophrénie. Puis, nous exposons dans un second article les résultats d’une recherche clinique sur les endocannabinoïdes plasmatiques dans trois groupes de sujets avec schizophrénie et/ou toxicomanie, pendant 12 semaines. Nous avons observé un effet miroir de deux ligands endocannabinoïdes, l’anandamide et l’oleylethanolamide, qui étaient élevés chez les patients avec double diagnostic et abaissés chez les toxicomanes, au début de l’étude. Au terme de l’étude, l’élévation des endocannabinoïdes s’est maintenue et nous avons supposé un marqueur de vulnérabilité psychotique dans un contexte de consommation. Finalement, nous avons analysé les résultats en les intégrant aux connaissances moléculaires et pharmacologiques ainsi qu’aux théories neurochimiques et inflammatoires déjà développées dans la schizophrénie. Nous avons aussi tenu compte des principales comorbidités observées en clinique: la toxicomanie et les troubles métaboliques. Cela nous a permis de proposer un modèle cannabinoïde de la schizophrénie et conséquemment des perspectives de recherche et de traitement. / Schizophrenia is a complex disease that has 1% worldwide prevalence. Dopamine etiological theory leads neurochemical paradigms although glutamate hypothesis is gaining in importance among several neurotransmission circuits involved. Schizophrenia patients are more prone to substance use disorders, particularly to cannabis dependence, than the general population. Therefore, we have aimed to explain the hypothesis of a deregulation in the endogenous cannabinoid system, a very important neurodulator.  First, this thesis proposes in the first article an exhaustive literature review on the endocannabinoid system and its implications in schizophrenia. Then, we present results from our clinical research on plasmatic endocannabinoids in three groups of subjects with schizophrenia and/or substance use disorders, during twelve weeks. We have observed a mirror effect involving two endocannabinoid ligands, anandamide and oleylethanolamide, which were elevated in patients with dual diagnosis and reduced in patients with only substance use disorders. At the end of the study, it seems that endocannabinoid elevation was maintained and we supposed a vulnerability to psychosis in a substance use disorder context.   Finally, we analyzed our results by integrating explanations from molecular biology and neuropharmacology and also from neurochemical and inflammatory theories already well-known in schizophrenia. We also considered the main comorbidities observed in clinic such as substance use and metabolic disorders. Then, we proposed an endogenous cannabinoid model of schizophrenia. Ultimately, this thesis suggested research perspectives and potential treatments.

Au cours du développement, les axones des cellules ganglionnaires de la rétine (CGRs) voyagent sur de longues distances pour établir des connexions avec leurs cellules cibles. La navigation des cônes de croissance est guidée par différentes molécules chimiotropiques présentes dans leur environnement. Les endocannabinoïdes (eCB) sont d’importants neuromodulateurs qui régulent de manière rétrograde la fonction de nombreuses synapses du cerveau. Ils agissent principalement par le biais de leurs récepteurs liés à une protéine Gi/o CB1 (CB1R) et CB2 (CB2R). La présence des eCBs durant le stade fœtal et la période postnatale suggère leur implication dans des événements régulant le développement du système nerveux. Cette thèse confirme l’expression des récepteurs aux cannabinoïdes CB1 et CB2 ainsi que l’enzyme dégradant les eCBs lors du développement embryonnaire et perinatal des CGRs et de la voie rétinothalamique in vivo. La manipulation pharmacologique de l’activité de CB1R et CB2R réorganise la morphologie du cône de croissance des CGRs et des neurones corticaux in vitro. De plus, la stimulation locale avec un agoniste de CB1R ou de CB2R modifie le comportement du cône de croissance entraînant sa répulsion. CB1R et CB2R modulent par le biais de la voie de signalisation AMPc/PKA, la mobilisation de DCC à la membrane plasmique. Par ailleurs, les résultats de cette recherche démontrent également l’implication de CB1R et CB2R dans la ségrégation des projections ipsi- et controlatérales et le développement de la voie rétinothalamique. / Following differentiation, retinal ganglion cell (RGC) axons, tipped at their distal end by the growth cone (GC), navigate through relatively long distances in a highly directed manner in order to establish functional synapses with thalamic and superior colliculus (SC) neurons. This is achieved with the help of extracellular guidance molecules which steer RGC axon growth by regulating GC morphology by means of attractive and/or repulsive mechanisms. In the adult brain, endocannabinoids (eCBs) exert an important neuromodulatory function by acting as retrograde messengers to regulate the function of many synapses. Endocannabinoids act mainly via their Gi/o protein coupled receptors CB1 (CB1R) and CB2 (CB2R). Due to their presence at the fetal and early postnatal periods, it has been proposed that eCBs and their receptors might be involved in several developmental events, such as cell proliferation and migration, axon guidance and synaptogenesis. We observed that during early postnatal development, components of the eCB system are expressed along the visual pathway (the optic chiasm, the lateral geniculate nucleus and the SC). To assess the implication of the eCB system, in vitro, embryonic retinal explant and primary neuron cultures were treated with pharmacological agonists and inverse agonists of CB1R and CB2R. These experiments demonstrated that these cannabinoid receptors modify the GC’s morphology. Most importantly, CB1R and CB2R act through the cAMP/PKA pathway to modulate the presence of DCC at the plasma membrane. In vivo, CB1R and CB2R play a major role and the absence of either one of them induces a decrease in eye-specific segregation of retinal projections. These results show an implication of CB1R and CB2R during RGC growth and retinothalamic development.

Phytocannabinoids are the active substances responsible for the medicinal and psychotropic effects of Cannabis sativa. Although the bioactivity of cannabis and its preparations have been known for millennia, several steps in the biosynthetic pathway leading to phytocannabinoids remain unclear. Phytocannabinoids are prenylated resorcylic acids which are formed in specialized plant organs called glandular trichomes. Following the analysis of a pre-generated cannabis trichome cDNA library, a type III polyketide synthase (tetraketide synthase; TKS) was identified and assayed, yielding three major compounds, hexanoyl triacetic acid lactone (HTAL), pentyl diacetic acid lactone (PDAL), and olivetol, yet no resorcylic acid was detected. This lack of resorcylic acid in enzyme assays has instigated the characterization of TKS and a search for putative cyclases in the cannabis trichome cDNA library, and involved protein pulldown, co-immunoprecipitation, and co-assay experiments. These experiments led to the discovery of a novel polyketide cyclase protein named olivetolic acid cyclase (OAC) responsible for the proper cyclization of a polyketide intermediate produced by TKS. This thesis shows that TKS assays conducted with OAC produce olivetolic acid (OA), an intermediate required during the biosynthesis of cannabinoids. The TKS/OAC spatial relationship was also investigated following the creation of fluorescent fusion proteins which show that the enzymes co-localized in vivo when viewed with confocal microscopy. Furthermore, yeast two-hybrid assays using TKS and OAC were performed to establish whether the enzymes physically interact. Finally, an attempt to determine the responsible amino acids involved in OAC’s mechanism was conducted by comparing the activity of single point OAC mutants with the wild-type OAC. Based on the available data, mechanisms for the production of HTAL, PDAL, olivetol, and OA are proposed.

Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal

O sistema canabinóide parece participar de vários processos neurobiológicos, incluindo neuroproteção e plasticidade. Os objetivos deste estudo foram avaliar os efeitos de ablações retinianas sobre a expressão do receptor canabinóide CB1 e de proteínas estruturais no tecto óptico de pintos pelos métodos de imuno-histoquímica, immunoblotting e PCR em tempo real. Além disso, avaliamos os efeitos do tratamento com agonistas e antagonistas canabinóides em culturas de células do tecto óptico expostas ao NMDA por citometria de fluxo e quanto à morfologia. A ablação retiniana parece gerar um aumento da expressão da proteína CB1 no tecto óptico desaferentado, mas não dos níveis de RNAm. O tratamento das culturas com o agonista canabinóide diminuiu o número de células inviáveis e de DNA fragmentado gerados pelo NMDA. O aumento da expressão de CB1 após a ablação indica uma localização pós-sináptica desses receptores e sugere um papel do sistema canabinóide em processos de plasticidade. Os resultados da cultura de células sugerem um papel neuroprotetor do sistema canabinóide. / The cannabinoid system (CS) seems to have a role in several neurobiological processes, including neuroprotection and neuronal plasticity. The aims of this study were to verify the effects of unilateral retinal ablation on the expression of cannabinoid receptor CB1 and other structural proteins in the optic tectum of chick brain by immunohistochemistry, immunoblotting and real time PCR. Moreover, we evaluated the effects of cannabinoids agonists and antagonists treatment in optic tectum cell cultures exposed to the NMDA by flow cytometry and in the morphology. The retinal ablation seems to generate an increase in the expression of protein CB1 in the deafferented optic tectum, but not in the levels of mRNA. The treatment of the cultures with the cannabinoid agonist decreased the number of unviable cells and fragmented DNAs generated by NMDA. This increase of CB1 expression indicates a post-synaptic localization of these receptors and suggests a role of the CS in plasticity processes. The results of cell culture suggest neuroprotector role of the CS.